-
1 day ago | 
rdworldonline.com | Tim Studt
The R&D World Index (RDWI) slid this week even as several companies rolled out big new R&D projects. For the week ending May 9, 2025, the index closed at 3,773.11, down 3.85% (–151.24 points). Sixteen of the 25 members fell. Eli Lilly & Co. was the biggest laggard (–10.81%) despite breaking ground on a huge research-and-manufacturing district. On the upside, General Motors gained 4.86% and Microsoft inched up 0.79%. Outside the market swoon, action was brisk.
-
1 month ago | 
rdworldonline.com | Tim Studt
Market volatility dominated the R&D landscape following President Trump’s tariff actions. The R&D World Index (RDWI) for the week ending April 4, 2025, reflected the initial shock, closing down a significant -9.28% at 3,506.27, with significant losses across all 25 member companies. Auto companies have been especially hard hit. To date, losses range from –1.44% for Ford to –14.21% for Stellantis. This uniform drop marks the first time this occurred in the Index’s history.
-
1 month ago | 
rdworldonline.com | Tim Studt
With a slight market rebound, the R&D World Index (RDWI) for the week ending March 21, 2025 closed at 3,970.87 for the 25 companies in the RDWI. The Index was up 0.48% (or 18.97 basis points). Fifteen RDWI members gained value last week from 0.46% (Alphabet/Google) to 3.49% (Bristol-Myers Squibb). Ten RDWI members lost value last week from -0.33% (Cisco) to -4.22% (Alibaba).
-
2 months ago | 
rdworldonline.com | Tim Studt
The R&D World Index (RDWI) for the week ending March 7, 2025, closed at 4,106.42 for the 25 companies in the RDWI. The Index dipped –1.37% (or -56.96 basis points). Seventeen RDWI members gained value last week from 0.08% (Stellantis NV) to 12.51% (Volkswagen AG). Eight RDWI members lost value the previous week from -0.25% (Cisco) to -13.06% (Intel).
-
2 months ago | 
rdworldonline.com | Tim Studt
The R&D World Index saw a slight gain last week amidst a landscape of innovation and cost-cutting within global industries. Pharma giants Eli Lilly and Merck announced a partnership with Purdue University to launch the Young Institute Pharmaceutical Manufacturing Consortium, aimed at bolstering domestic pharmaceutical production.
-
2 months ago | 
rdworldonline.com | Tim Studt
The R&D World Index saw gains this week, driven partly by a surge in Intel’s value amid significant developments across various sectors. Honda and Nissan have ended their merger talks, citing concerns over autonomy and decision-making, while GlaxoSmithKline consolidates its vaccine R&D in Cambridge, MA. Novartis is set to reacquire rights to a blood clot treatment with a multi-billion dollar deal. Chevron announced a headquarters relocation to Houston and workforce reductions.
-
Jan 20, 2025 | 
rdworldonline.com | Tim Studt
Welcome to our weekly briefing on R&D headlines that are shaping technology, healthcare, and industry. In this edition, we explore NVIDIA’s global expansion plans (plus a sharp rebuttal to new U.S. AI policy), Google’s ambitious Gemini user goals, a big-ticket pharma acquisition, tighter U.S. chip controls, and more. Keep reading for the latest developments and a snapshot of how top R&D firms are faring in the market.
-
Jan 6, 2025 | 
rdworldonline.com | Tim Studt
The R&D World Index (RDWI) for the week ending January 3, 2025, closed at 3,862.49 for the 25 companies in the RDWI — down –0.72% (or -28.10 basis points). Five RDWI members gained value last week, led by AbbVie (+1.80%), while Roche Holdings AG rose the least (+0.31%). Meanwhile, twenty RDWI members dipped, ranging from a slight -0.02% (Astra Zeneca) to –1.81% (Apple).
-
Dec 30, 2024 | 
rdworldonline.com | Tim Studt
The R&D World Index (RDWI) for the week ending December 27, 2024, closed at 3,890.59, rising 1.77% (or 67.68 basis points). Automotive stocks, in particular, drove the uptick, with Honda surging by 20.39% after announcing a merger plan with Nissan. Meanwhile, tech giants showed mixed results, as IBM slid slightly (-0.26%) and Microsoft dropped -1.38%.
-
Dec 23, 2024 | 
rdworldonline.com | Tim Studt
Volkswagen AG, a member of the R&D World Index, announced a significant workforce reduction last week, agreeing with its labor union to cut over 35,000 jobs and billions of dollars in costs, concluding three months of intense negotiations and narrowly avoiding factory closures in Germany. In other news, Merck & Co. invested strategically in Chinese weight loss drug development, signing a $112 million upfront deal with Hansoh Pharma that could reach $1.9 billion with milestones.
